Ipsen Presents Comprehensive Data Showing ‘Survival Benefit’ In Pancreatic Cancer In Phase 3 Trial
gorodenkoff Ipsen (OTCPK:IPSEY) (OTCPK:IPSEF) presented complete data from a Phase 3 trial showing that its drug Onivyde helped improve overall ...
gorodenkoff Ipsen (OTCPK:IPSEY) (OTCPK:IPSEF) presented complete data from a Phase 3 trial showing that its drug Onivyde helped improve overall ...
Nastassia Samal Biopharmaceutical company Albireo Pharma (NASDAQ: WHITE) as a reaction to its agreement to be acquired by the French ...